6 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... response preceding infection ... like illnesses, COVID ... Clinical Features ... #diagnosis #management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... Cytokine Activation Syndrome ... respiratory tract infection ... #Pharmacology # ... Management #Medications
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
-19 Infection ... highlighted circle= clinical ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology # ... Table #Management
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... transplantation CLINICAL ... #Barre #Syndrome ... #diagnosis #management ... #neurology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Preeclampsia, Eclampsia, Infection ... Diagnosis: • Infection ... Electrolyte abnormality, Medication ... #diagnosis #management ... #neurology
Opsoclonus Myoclonus Syndrome (OMS) on Physical Exam

Opsoclonus: Rapid, repetitive conjugate involuntary chaotic multidirectional (horizontal, vertical, and
Opsoclonus Myoclonus Syndrome ... occur as a para-infectious ... COVID manifestation ... PhysicalExam #ocular #clinical ... #video #eyes #neurology